Exchange: OTC·Updated 09:34 AM EST

MYNDF MYND Life Sciences Inc

$0.0081
$0.0129
(61.43%)
Today
Mkt Cap$387,300.00
Vol2,500.00

About MYNDF

MYND Life Sciences, Inc. is a neuro-pharmaceutical drug development company. It develops medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on Major Depressive Disorder (“MDD”). The company was founded by Dr. Lyle Oberg and Dr. Wilfred Jefferies on July 6, 2018 and is headquartered in Kelowna, Canada.
63

Bullish Sentiment

How do you feel about MYNDF?

Advertisement|Remove ads.